TORONTO, Jan. 17, 2019 /CNW/ - CBx Data Labs is expanding its expertise and knowledge base through the establishment of an esteemed advisory board of cannabis, government, health, law and business leaders. Today, CBx Data Labs is pleased to announce the addition of John Ruffolo to its Advisory Board.
CBx Data Labs is a medical cannabis leader with its cloud-based HIPAA compliant data collection platform that collects condition and symptom specific patient feedback and makes the data available to practitioners and medication formulators. CBx Data Labs continues to grow quickly in the North American medical cannabis market and will benefit greatly from the expertise provided by this advisory board.
"We are incredibly excited to have John join our advisory board", said Chad Walsh, CEO of CBx Data Labs. "With the addition of John, one of Canada's top tech minds, to an incredibly knowledgeable and successful group of individuals that recognize the strategic offering that CBx Data Labs provides specifically to the medical cannabis market."
John is the founder of OMERS Ventures as well as the co-founder and Vice-Chair of the Council of Canadian Innovators. In addition, John serves on several boards including Hootsuite, Ether Capital, Ontario Centres of Excellence, David Suzuki Foundation, Royal Ontario Museum, and the NHL Coaches Association. John also served as the CEO of OMERS Ventures and the Executive Managing Director of OMERS Platform Investments. Prior to joining OMERS, he was a Partner at Deloitte where he was the Global Thought Leader, the Global Tax Leader and the Canadian Industry Leader for Deloitte's Technology, Media and Telecommunications practice and a member of Deloitte's Board of Directors.
In addition to John, CBx Data Labs have announced a full advisory board that includes:
About CBx Data Labs
CBx Data Labs develops software tools to collect and enable patient data to be better analyzed in market for medical cannabis. Harnessing this type of data through uniquely-designed healthcare applications will establish an evidence base for specific formulas, give both patients and health professionals the ability to better manage the full cycle of care, while also allowing professional organizations, researchers, governments and industry to better understand and validate how a particular course of care is being used in practice.
SOURCE CBx Data Labs
These press releases may also interest you